Patented biomarker for cardiac injury. 

Anthracyclines and Biomarkers of Myocardial Injury: The Effect of Remote Ischemic Conditioning (RIC)

Background

Remote ischemic conditioning (RIC) has been beneficial in laboratory studies of anthracycline cardiotoxicity, but its effects in patients is not established.

Objectives

We studied the effect of RIC on cardiac biomarkers and function during and after anthracycline chemotherapy.

Conclusion

TnT and cMyC significantly increased during anthracycline chemotherapy.

cMyC (Cardiac Myosin-binding protein C)
cMyC (Cardiac Myosin-binding protein C)